APA (7th ed.) Citation

Sanden, S. V., Youssef, A., Baculea, S., Stubbs, K., Triantos, S., Yuan, Z., & Daly, C. Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial Carcinoma. Columbia Data Analytics, LLC.

Chicago Style (17th ed.) Citation

Sanden, Suzy Van, Ayman Youssef, Simona Baculea, Keith Stubbs, Spyros Triantos, Zijiao Yuan, and Caitlin Daly. Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib Vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial Carcinoma. Columbia Data Analytics, LLC.

MLA (9th ed.) Citation

Sanden, Suzy Van, et al. Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Erdafitinib Vs Enfortumab Vedotin in Patients with Locally Advanced Metastatic Urothelial Carcinoma. Columbia Data Analytics, LLC.